Novo Nordisk A/S
NONOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $100,988 | $83,683 | $55,525 | $47,757 |
| Dep. & Amort. | $8,545 | $9,413 | $7,362 | $6,025 |
| Deferred Tax | $26,203 | $20,991 | $13,537 | $11,323 |
| Stock-Based Comp. | $2,289 | $2,149 | $1,539 | $1,040 |
| Change in WC | -$11,995 | -$12,245 | -$5,336 | -$8,656 |
| Other Non-Cash | -$5,062 | $4,917 | $6,459 | -$2,489 |
| Operating Cash Flow | $120,968 | $108,908 | $78,887 | $55,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$47,164 | -$25,806 | -$12,146 | -$7,385 |
| Net Acquisitions | -$82,163 | $0 | -$7,075 | -$18,283 |
| Inv. Purchases | -$19,814 | -$13,289 | -$9,735 | -$7,113 |
| Inv. Sales/Matur. | $24,391 | $8,293 | $6,645 | $1,172 |
| Other Inv. Act. | -$4,145 | -$13,090 | -$2,607 | -$1,046 |
| Investing Cash Flow | -$128,895 | -$43,892 | -$24,918 | -$31,605 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $73,056 | -$1,467 | -$2,408 | $15,471 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$20,181 | -$29,924 | -$24,086 | -$19,447 |
| Dividends Paid | -$44,140 | -$31,767 | -$25,303 | -$21,517 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $8,735 | -$63,158 | -$51,797 | -$25,493 |
| Forex Effect | $455 | -$119 | -$238 | $591 |
| Net Chg. in Cash | $1,263 | $1,739 | $1,934 | -$1,507 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,392 | $12,653 | $10,719 | $12,226 |
| End Cash | $15,655 | $14,392 | $12,653 | $10,719 |
| Free Cash Flow | $69,659 | $70,012 | $64,134 | $47,615 |